“First Generics” Will Get Expedited ANDA Reviews Under New FDA Policy

FDA's "First Generics" policy sets a priority review goal of six months for ANDAs for which there is no marketed generic equivalent

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet